Interferon beta 1a (IFN-beta1a)

Preeclampsia

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S3709
R7917		 Fragoso a (control exposed to Glatiramer), 2013 Preeclampsia during pregnancy (anytime or not specified) retrospective cohort exposed to other treatment, sick excluded Adjustment: No 0.66 [0.06;7.66] C
excluded (control group) 		1/29   2/39 3 29
ref
S3711
R7955		 Fragoso a (control unexposed, sick), 2013 Preeclampsia during pregnancy (anytime or not specified) retrospective cohort unexposed, sick Adjustment: No 1.10 [0.11;10.95] C 1/29   3/95 4 29
ref
Total 1 studies 1.10 [0.11;10.95] 4 29
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Fragoso a (control unexposed, sick), 2013Fragoso a, 2013 1 1.10[0.11; 10.95]4290%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA0.55.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: control unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.10[0.11; 10.95]429 -NAFragoso a (control unexposed, sick), 2013 1 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 1.10[0.11; 10.95]429 -NAFragoso a (control unexposed, sick), 2013 1 Tags Adjustment   - No  - No 1.10[0.11; 10.95]429 -NAFragoso a (control unexposed, sick), 2013 1 All studiesAll studies 1.10[0.11; 10.95]429 -NAFragoso a (control unexposed, sick), 2013 10.55.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 3709

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed, sick controlsunexposed, sick controls 1.10[0.11; 10.95]429 -NAFragoso a (control unexposed, sick), 2013 1 exposed to other treatment, sick controlsexposed to other treatment, sick controls 0.66[0.06; 7.66]329 -NAFragoso a (control exposed to Glatiramer), 2013 10.510.01.0